ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Rapid Diagnostic Testing for Influenza Market Research Report 2024
Published Date: June 2024
|
Report Code: QYRE-Auto-8X5991
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Rapid Diagnostic Testing for Influenza Market Size Status and Forecast 2021 2027
BUY CHAPTERS

Global Rapid Diagnostic Testing for Influenza Market Research Report 2024

Code: QYRE-Auto-8X5991
Report
June 2024
Pages:97
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
BD
Abbot (Alere)
Quidel
Roche
Thermo Fisher Scientific
Meridian Bioscience
Analytik Jena
Princeton BioMeditech Corporation
Biomerieux
Sekisui Diagnostics
Response Biomedical
SA Scientific
DiaSorin (Focus Diagnostics)
Wondfo
Beijing Wantai Biological Pharmacy

Rapid Diagnostic Testing for Influenza Market Size

The global Rapid Diagnostic Testing for Influenza market was valued at US$ 1269 million in 2023 and is anticipated to reach US$ 1578.1 million by 2030, witnessing a CAGR of 3.1% during the forecast period 2024-2030.

Rapid Diagnostic Testing for Influenza Market

Rapid Diagnostic Testing for Influenza Market

Rapid influenza diagnostic tests (RIDTs) are immunoassays that can identify the presence of influenza A and B viral nucleoprotein antigens in respiratory specimens, and display the result in a qualitative way (positive vs. negative). In the United States, a number of RIDTs are commercially available. The reference standards for laboratory confirmation of influenza virus infection in respiratory specimens are reverse transcription-polymerase chain reaction (RT-PCR) or viral culture. RIDTs can yield results in a clinically relevant time frame, i.e., less than approximately 15 minutes. However, RIDTs have limited sensitivity to detect influenza viruses in respiratory specimens compared to RT-PCR or viral culture and negative RIDT test results should be interpreted with caution given the potential for false negative results, especially during peak influenza activity in a community. Some RIDTs use analyzer reader devices to standardize result interpretation.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Rapid Diagnostic Testing for Influenza, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rapid Diagnostic Testing for Influenza.

Report Scope

The Rapid Diagnostic Testing for Influenza market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Rapid Diagnostic Testing for Influenza market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Rapid Diagnostic Testing for Influenza companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Rapid Diagnostic Testing for Influenza Market Report

Report Metric Details
Report Name Rapid Diagnostic Testing for Influenza Market
Accounted market size in 2023 US$ 1269 million
Forecasted market size in 2030 US$ 1578.1 million
CAGR 3.1%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
  • Digital RIDTs
  • Conventional RIDT
Segment by Application
  • Hospitals
  • POCT
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company BD, Abbot (Alere), Quidel, Roche, Thermo Fisher Scientific, Meridian Bioscience, Analytik Jena, Princeton BioMeditech Corporation, BioMerieux, Sekisui Diagnostics, Response Biomedical, SA Scientific, DiaSorin (Focus Diagnostics), Wondfo, Beijing Wantai Biological Pharmacy
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Rapid Diagnostic Testing for Influenza companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Rapid Diagnostic Testing for Influenza Market growing?

Ans: The Rapid Diagnostic Testing for Influenza Market witnessing a CAGR of 3.1% during the forecast period 2024-2030.

What is the Rapid Diagnostic Testing for Influenza Market size in 2030?

Ans: The Rapid Diagnostic Testing for Influenza Market size in 2030 will be US$ 1578.1 million.

Who are the main players in the Rapid Diagnostic Testing for Influenza Market report?

Ans: The main players in the Rapid Diagnostic Testing for Influenza Market are BD, Abbot (Alere), Quidel, Roche, Thermo Fisher Scientific, Meridian Bioscience, Analytik Jena, Princeton BioMeditech Corporation, BioMerieux, Sekisui Diagnostics, Response Biomedical, SA Scientific, DiaSorin (Focus Diagnostics), Wondfo, Beijing Wantai Biological Pharmacy

What are the Application segmentation covered in the Rapid Diagnostic Testing for Influenza Market report?

Ans: The Applications covered in the Rapid Diagnostic Testing for Influenza Market report are Hospitals, POCT, Others

What are the Type segmentation covered in the Rapid Diagnostic Testing for Influenza Market report?

Ans: The Types covered in the Rapid Diagnostic Testing for Influenza Market report are Digital RIDTs, Conventional RIDT

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Rapid Diagnostic Testing for Influenza Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Digital RIDTs
1.2.3 Conventional RIDT
1.3 Market by Application
1.3.1 Global Rapid Diagnostic Testing for Influenza Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 POCT
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Rapid Diagnostic Testing for Influenza Market Perspective (2019-2030)
2.2 Rapid Diagnostic Testing for Influenza Growth Trends by Region
2.2.1 Global Rapid Diagnostic Testing for Influenza Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Rapid Diagnostic Testing for Influenza Historic Market Size by Region (2019-2024)
2.2.3 Rapid Diagnostic Testing for Influenza Forecasted Market Size by Region (2025-2030)
2.3 Rapid Diagnostic Testing for Influenza Market Dynamics
2.3.1 Rapid Diagnostic Testing for Influenza Industry Trends
2.3.2 Rapid Diagnostic Testing for Influenza Market Drivers
2.3.3 Rapid Diagnostic Testing for Influenza Market Challenges
2.3.4 Rapid Diagnostic Testing for Influenza Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Rapid Diagnostic Testing for Influenza Players by Revenue
3.1.1 Global Top Rapid Diagnostic Testing for Influenza Players by Revenue (2019-2024)
3.1.2 Global Rapid Diagnostic Testing for Influenza Revenue Market Share by Players (2019-2024)
3.2 Global Rapid Diagnostic Testing for Influenza Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Rapid Diagnostic Testing for Influenza Revenue
3.4 Global Rapid Diagnostic Testing for Influenza Market Concentration Ratio
3.4.1 Global Rapid Diagnostic Testing for Influenza Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Rapid Diagnostic Testing for Influenza Revenue in 2023
3.5 Rapid Diagnostic Testing for Influenza Key Players Head office and Area Served
3.6 Key Players Rapid Diagnostic Testing for Influenza Product Solution and Service
3.7 Date of Enter into Rapid Diagnostic Testing for Influenza Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Rapid Diagnostic Testing for Influenza Breakdown Data by Type
4.1 Global Rapid Diagnostic Testing for Influenza Historic Market Size by Type (2019-2024)
4.2 Global Rapid Diagnostic Testing for Influenza Forecasted Market Size by Type (2025-2030)
5 Rapid Diagnostic Testing for Influenza Breakdown Data by Application
5.1 Global Rapid Diagnostic Testing for Influenza Historic Market Size by Application (2019-2024)
5.2 Global Rapid Diagnostic Testing for Influenza Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Rapid Diagnostic Testing for Influenza Market Size (2019-2030)
6.2 North America Rapid Diagnostic Testing for Influenza Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Rapid Diagnostic Testing for Influenza Market Size by Country (2019-2024)
6.4 North America Rapid Diagnostic Testing for Influenza Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Rapid Diagnostic Testing for Influenza Market Size (2019-2030)
7.2 Europe Rapid Diagnostic Testing for Influenza Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Rapid Diagnostic Testing for Influenza Market Size by Country (2019-2024)
7.4 Europe Rapid Diagnostic Testing for Influenza Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Rapid Diagnostic Testing for Influenza Market Size (2019-2030)
8.2 Asia-Pacific Rapid Diagnostic Testing for Influenza Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Rapid Diagnostic Testing for Influenza Market Size by Region (2019-2024)
8.4 Asia-Pacific Rapid Diagnostic Testing for Influenza Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Rapid Diagnostic Testing for Influenza Market Size (2019-2030)
9.2 Latin America Rapid Diagnostic Testing for Influenza Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Rapid Diagnostic Testing for Influenza Market Size by Country (2019-2024)
9.4 Latin America Rapid Diagnostic Testing for Influenza Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Rapid Diagnostic Testing for Influenza Market Size (2019-2030)
10.2 Middle East & Africa Rapid Diagnostic Testing for Influenza Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Rapid Diagnostic Testing for Influenza Market Size by Country (2019-2024)
10.4 Middle East & Africa Rapid Diagnostic Testing for Influenza Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 BD
11.1.1 BD Company Detail
11.1.2 BD Business Overview
11.1.3 BD Rapid Diagnostic Testing for Influenza Introduction
11.1.4 BD Revenue in Rapid Diagnostic Testing for Influenza Business (2019-2024)
11.1.5 BD Recent Development
11.2 Abbot (Alere)
11.2.1 Abbot (Alere) Company Detail
11.2.2 Abbot (Alere) Business Overview
11.2.3 Abbot (Alere) Rapid Diagnostic Testing for Influenza Introduction
11.2.4 Abbot (Alere) Revenue in Rapid Diagnostic Testing for Influenza Business (2019-2024)
11.2.5 Abbot (Alere) Recent Development
11.3 Quidel
11.3.1 Quidel Company Detail
11.3.2 Quidel Business Overview
11.3.3 Quidel Rapid Diagnostic Testing for Influenza Introduction
11.3.4 Quidel Revenue in Rapid Diagnostic Testing for Influenza Business (2019-2024)
11.3.5 Quidel Recent Development
11.4 Roche
11.4.1 Roche Company Detail
11.4.2 Roche Business Overview
11.4.3 Roche Rapid Diagnostic Testing for Influenza Introduction
11.4.4 Roche Revenue in Rapid Diagnostic Testing for Influenza Business (2019-2024)
11.4.5 Roche Recent Development
11.5 Thermo Fisher Scientific
11.5.1 Thermo Fisher Scientific Company Detail
11.5.2 Thermo Fisher Scientific Business Overview
11.5.3 Thermo Fisher Scientific Rapid Diagnostic Testing for Influenza Introduction
11.5.4 Thermo Fisher Scientific Revenue in Rapid Diagnostic Testing for Influenza Business (2019-2024)
11.5.5 Thermo Fisher Scientific Recent Development
11.6 Meridian Bioscience
11.6.1 Meridian Bioscience Company Detail
11.6.2 Meridian Bioscience Business Overview
11.6.3 Meridian Bioscience Rapid Diagnostic Testing for Influenza Introduction
11.6.4 Meridian Bioscience Revenue in Rapid Diagnostic Testing for Influenza Business (2019-2024)
11.6.5 Meridian Bioscience Recent Development
11.7 Analytik Jena
11.7.1 Analytik Jena Company Detail
11.7.2 Analytik Jena Business Overview
11.7.3 Analytik Jena Rapid Diagnostic Testing for Influenza Introduction
11.7.4 Analytik Jena Revenue in Rapid Diagnostic Testing for Influenza Business (2019-2024)
11.7.5 Analytik Jena Recent Development
11.8 Princeton BioMeditech Corporation
11.8.1 Princeton BioMeditech Corporation Company Detail
11.8.2 Princeton BioMeditech Corporation Business Overview
11.8.3 Princeton BioMeditech Corporation Rapid Diagnostic Testing for Influenza Introduction
11.8.4 Princeton BioMeditech Corporation Revenue in Rapid Diagnostic Testing for Influenza Business (2019-2024)
11.8.5 Princeton BioMeditech Corporation Recent Development
11.9 BioMerieux
11.9.1 BioMerieux Company Detail
11.9.2 BioMerieux Business Overview
11.9.3 BioMerieux Rapid Diagnostic Testing for Influenza Introduction
11.9.4 BioMerieux Revenue in Rapid Diagnostic Testing for Influenza Business (2019-2024)
11.9.5 BioMerieux Recent Development
11.10 Sekisui Diagnostics
11.10.1 Sekisui Diagnostics Company Detail
11.10.2 Sekisui Diagnostics Business Overview
11.10.3 Sekisui Diagnostics Rapid Diagnostic Testing for Influenza Introduction
11.10.4 Sekisui Diagnostics Revenue in Rapid Diagnostic Testing for Influenza Business (2019-2024)
11.10.5 Sekisui Diagnostics Recent Development
11.11 Response Biomedical
11.11.1 Response Biomedical Company Detail
11.11.2 Response Biomedical Business Overview
11.11.3 Response Biomedical Rapid Diagnostic Testing for Influenza Introduction
11.11.4 Response Biomedical Revenue in Rapid Diagnostic Testing for Influenza Business (2019-2024)
11.11.5 Response Biomedical Recent Development
11.12 SA Scientific
11.12.1 SA Scientific Company Detail
11.12.2 SA Scientific Business Overview
11.12.3 SA Scientific Rapid Diagnostic Testing for Influenza Introduction
11.12.4 SA Scientific Revenue in Rapid Diagnostic Testing for Influenza Business (2019-2024)
11.12.5 SA Scientific Recent Development
11.13 DiaSorin (Focus Diagnostics)
11.13.1 DiaSorin (Focus Diagnostics) Company Detail
11.13.2 DiaSorin (Focus Diagnostics) Business Overview
11.13.3 DiaSorin (Focus Diagnostics) Rapid Diagnostic Testing for Influenza Introduction
11.13.4 DiaSorin (Focus Diagnostics) Revenue in Rapid Diagnostic Testing for Influenza Business (2019-2024)
11.13.5 DiaSorin (Focus Diagnostics) Recent Development
11.14 Wondfo
11.14.1 Wondfo Company Detail
11.14.2 Wondfo Business Overview
11.14.3 Wondfo Rapid Diagnostic Testing for Influenza Introduction
11.14.4 Wondfo Revenue in Rapid Diagnostic Testing for Influenza Business (2019-2024)
11.14.5 Wondfo Recent Development
11.15 Beijing Wantai Biological Pharmacy
11.15.1 Beijing Wantai Biological Pharmacy Company Detail
11.15.2 Beijing Wantai Biological Pharmacy Business Overview
11.15.3 Beijing Wantai Biological Pharmacy Rapid Diagnostic Testing for Influenza Introduction
11.15.4 Beijing Wantai Biological Pharmacy Revenue in Rapid Diagnostic Testing for Influenza Business (2019-2024)
11.15.5 Beijing Wantai Biological Pharmacy Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
FEATURED COMPANIES
BD
Abbot (Alere)
Quidel
Roche
Thermo Fisher Scientific
Meridian Bioscience
Analytik Jena
Princeton BioMeditech Corporation
Biomerieux
Sekisui Diagnostics
Response Biomedical
SA Scientific
DiaSorin (Focus Diagnostics)
Wondfo
Beijing Wantai Biological Pharmacy
List of Tables
    Table 1. Global Rapid Diagnostic Testing for Influenza Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
    Table 2. Key Players of Digital RIDTs
    Table 3. Key Players of Conventional RIDT
    Table 4. Global Rapid Diagnostic Testing for Influenza Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
    Table 5. Global Rapid Diagnostic Testing for Influenza Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 6. Global Rapid Diagnostic Testing for Influenza Market Size by Region (2019-2024) & (US$ Million)
    Table 7. Global Rapid Diagnostic Testing for Influenza Market Share by Region (2019-2024)
    Table 8. Global Rapid Diagnostic Testing for Influenza Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 9. Global Rapid Diagnostic Testing for Influenza Market Share by Region (2025-2030)
    Table 10. Rapid Diagnostic Testing for Influenza Market Trends
    Table 11. Rapid Diagnostic Testing for Influenza Market Drivers
    Table 12. Rapid Diagnostic Testing for Influenza Market Challenges
    Table 13. Rapid Diagnostic Testing for Influenza Market Restraints
    Table 14. Global Rapid Diagnostic Testing for Influenza Revenue by Players (2019-2024) & (US$ Million)
    Table 15. Global Rapid Diagnostic Testing for Influenza Market Share by Players (2019-2024)
    Table 16. Global Top Rapid Diagnostic Testing for Influenza Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rapid Diagnostic Testing for Influenza as of 2023)
    Table 17. Ranking of Global Top Rapid Diagnostic Testing for Influenza Companies by Revenue (US$ Million) in 2023
    Table 18. Global 5 Largest Players Market Share by Rapid Diagnostic Testing for Influenza Revenue (CR5 and HHI) & (2019-2024)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Rapid Diagnostic Testing for Influenza Product Solution and Service
    Table 21. Date of Enter into Rapid Diagnostic Testing for Influenza Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Rapid Diagnostic Testing for Influenza Market Size by Type (2019-2024) & (US$ Million)
    Table 24. Global Rapid Diagnostic Testing for Influenza Revenue Market Share by Type (2019-2024)
    Table 25. Global Rapid Diagnostic Testing for Influenza Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 26. Global Rapid Diagnostic Testing for Influenza Revenue Market Share by Type (2025-2030)
    Table 27. Global Rapid Diagnostic Testing for Influenza Market Size by Application (2019-2024) & (US$ Million)
    Table 28. Global Rapid Diagnostic Testing for Influenza Revenue Market Share by Application (2019-2024)
    Table 29. Global Rapid Diagnostic Testing for Influenza Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 30. Global Rapid Diagnostic Testing for Influenza Revenue Market Share by Application (2025-2030)
    Table 31. North America Rapid Diagnostic Testing for Influenza Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 32. North America Rapid Diagnostic Testing for Influenza Market Size by Country (2019-2024) & (US$ Million)
    Table 33. North America Rapid Diagnostic Testing for Influenza Market Size by Country (2025-2030) & (US$ Million)
    Table 34. Europe Rapid Diagnostic Testing for Influenza Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 35. Europe Rapid Diagnostic Testing for Influenza Market Size by Country (2019-2024) & (US$ Million)
    Table 36. Europe Rapid Diagnostic Testing for Influenza Market Size by Country (2025-2030) & (US$ Million)
    Table 37. Asia-Pacific Rapid Diagnostic Testing for Influenza Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 38. Asia-Pacific Rapid Diagnostic Testing for Influenza Market Size by Region (2019-2024) & (US$ Million)
    Table 39. Asia-Pacific Rapid Diagnostic Testing for Influenza Market Size by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Rapid Diagnostic Testing for Influenza Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 41. Latin America Rapid Diagnostic Testing for Influenza Market Size by Country (2019-2024) & (US$ Million)
    Table 42. Latin America Rapid Diagnostic Testing for Influenza Market Size by Country (2025-2030) & (US$ Million)
    Table 43. Middle East & Africa Rapid Diagnostic Testing for Influenza Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 44. Middle East & Africa Rapid Diagnostic Testing for Influenza Market Size by Country (2019-2024) & (US$ Million)
    Table 45. Middle East & Africa Rapid Diagnostic Testing for Influenza Market Size by Country (2025-2030) & (US$ Million)
    Table 46. BD Company Detail
    Table 47. BD Business Overview
    Table 48. BD Rapid Diagnostic Testing for Influenza Product
    Table 49. BD Revenue in Rapid Diagnostic Testing for Influenza Business (2019-2024) & (US$ Million)
    Table 50. BD Recent Development
    Table 51. Abbot (Alere) Company Detail
    Table 52. Abbot (Alere) Business Overview
    Table 53. Abbot (Alere) Rapid Diagnostic Testing for Influenza Product
    Table 54. Abbot (Alere) Revenue in Rapid Diagnostic Testing for Influenza Business (2019-2024) & (US$ Million)
    Table 55. Abbot (Alere) Recent Development
    Table 56. Quidel Company Detail
    Table 57. Quidel Business Overview
    Table 58. Quidel Rapid Diagnostic Testing for Influenza Product
    Table 59. Quidel Revenue in Rapid Diagnostic Testing for Influenza Business (2019-2024) & (US$ Million)
    Table 60. Quidel Recent Development
    Table 61. Roche Company Detail
    Table 62. Roche Business Overview
    Table 63. Roche Rapid Diagnostic Testing for Influenza Product
    Table 64. Roche Revenue in Rapid Diagnostic Testing for Influenza Business (2019-2024) & (US$ Million)
    Table 65. Roche Recent Development
    Table 66. Thermo Fisher Scientific Company Detail
    Table 67. Thermo Fisher Scientific Business Overview
    Table 68. Thermo Fisher Scientific Rapid Diagnostic Testing for Influenza Product
    Table 69. Thermo Fisher Scientific Revenue in Rapid Diagnostic Testing for Influenza Business (2019-2024) & (US$ Million)
    Table 70. Thermo Fisher Scientific Recent Development
    Table 71. Meridian Bioscience Company Detail
    Table 72. Meridian Bioscience Business Overview
    Table 73. Meridian Bioscience Rapid Diagnostic Testing for Influenza Product
    Table 74. Meridian Bioscience Revenue in Rapid Diagnostic Testing for Influenza Business (2019-2024) & (US$ Million)
    Table 75. Meridian Bioscience Recent Development
    Table 76. Analytik Jena Company Detail
    Table 77. Analytik Jena Business Overview
    Table 78. Analytik Jena Rapid Diagnostic Testing for Influenza Product
    Table 79. Analytik Jena Revenue in Rapid Diagnostic Testing for Influenza Business (2019-2024) & (US$ Million)
    Table 80. Analytik Jena Recent Development
    Table 81. Princeton BioMeditech Corporation Company Detail
    Table 82. Princeton BioMeditech Corporation Business Overview
    Table 83. Princeton BioMeditech Corporation Rapid Diagnostic Testing for Influenza Product
    Table 84. Princeton BioMeditech Corporation Revenue in Rapid Diagnostic Testing for Influenza Business (2019-2024) & (US$ Million)
    Table 85. Princeton BioMeditech Corporation Recent Development
    Table 86. BioMerieux Company Detail
    Table 87. BioMerieux Business Overview
    Table 88. BioMerieux Rapid Diagnostic Testing for Influenza Product
    Table 89. BioMerieux Revenue in Rapid Diagnostic Testing for Influenza Business (2019-2024) & (US$ Million)
    Table 90. BioMerieux Recent Development
    Table 91. Sekisui Diagnostics Company Detail
    Table 92. Sekisui Diagnostics Business Overview
    Table 93. Sekisui Diagnostics Rapid Diagnostic Testing for Influenza Product
    Table 94. Sekisui Diagnostics Revenue in Rapid Diagnostic Testing for Influenza Business (2019-2024) & (US$ Million)
    Table 95. Sekisui Diagnostics Recent Development
    Table 96. Response Biomedical Company Detail
    Table 97. Response Biomedical Business Overview
    Table 98. Response Biomedical Rapid Diagnostic Testing for Influenza Product
    Table 99. Response Biomedical Revenue in Rapid Diagnostic Testing for Influenza Business (2019-2024) & (US$ Million)
    Table 100. Response Biomedical Recent Development
    Table 101. SA Scientific Company Detail
    Table 102. SA Scientific Business Overview
    Table 103. SA Scientific Rapid Diagnostic Testing for Influenza Product
    Table 104. SA Scientific Revenue in Rapid Diagnostic Testing for Influenza Business (2019-2024) & (US$ Million)
    Table 105. SA Scientific Recent Development
    Table 106. DiaSorin (Focus Diagnostics) Company Detail
    Table 107. DiaSorin (Focus Diagnostics) Business Overview
    Table 108. DiaSorin (Focus Diagnostics) Rapid Diagnostic Testing for Influenza Product
    Table 109. DiaSorin (Focus Diagnostics) Revenue in Rapid Diagnostic Testing for Influenza Business (2019-2024) & (US$ Million)
    Table 110. DiaSorin (Focus Diagnostics) Recent Development
    Table 111. Wondfo Company Detail
    Table 112. Wondfo Business Overview
    Table 113. Wondfo Rapid Diagnostic Testing for Influenza Product
    Table 114. Wondfo Revenue in Rapid Diagnostic Testing for Influenza Business (2019-2024) & (US$ Million)
    Table 115. Wondfo Recent Development
    Table 116. Beijing Wantai Biological Pharmacy Company Detail
    Table 117. Beijing Wantai Biological Pharmacy Business Overview
    Table 118. Beijing Wantai Biological Pharmacy Rapid Diagnostic Testing for Influenza Product
    Table 119. Beijing Wantai Biological Pharmacy Revenue in Rapid Diagnostic Testing for Influenza Business (2019-2024) & (US$ Million)
    Table 120. Beijing Wantai Biological Pharmacy Recent Development
    Table 121. Research Programs/Design for This Report
    Table 122. Key Data Information from Secondary Sources
    Table 123. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Rapid Diagnostic Testing for Influenza Market Size Comparison by Type (2024-2030) & (US$ Million)
    Figure 2. Global Rapid Diagnostic Testing for Influenza Market Share by Type: 2023 VS 2030
    Figure 3. Digital RIDTs Features
    Figure 4. Conventional RIDT Features
    Figure 5. Global Rapid Diagnostic Testing for Influenza Market Size Comparison by Application (2024-2030) & (US$ Million)
    Figure 6. Global Rapid Diagnostic Testing for Influenza Market Share by Application: 2023 VS 2030
    Figure 7. Hospitals Case Studies
    Figure 8. POCT Case Studies
    Figure 9. Others Case Studies
    Figure 10. Rapid Diagnostic Testing for Influenza Report Years Considered
    Figure 11. Global Rapid Diagnostic Testing for Influenza Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 12. Global Rapid Diagnostic Testing for Influenza Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 13. Global Rapid Diagnostic Testing for Influenza Market Share by Region: 2023 VS 2030
    Figure 14. Global Rapid Diagnostic Testing for Influenza Market Share by Players in 2023
    Figure 15. Global Top Rapid Diagnostic Testing for Influenza Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rapid Diagnostic Testing for Influenza as of 2023)
    Figure 16. The Top 10 and 5 Players Market Share by Rapid Diagnostic Testing for Influenza Revenue in 2023
    Figure 17. North America Rapid Diagnostic Testing for Influenza Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 18. North America Rapid Diagnostic Testing for Influenza Market Share by Country (2019-2030)
    Figure 19. United States Rapid Diagnostic Testing for Influenza Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 20. Canada Rapid Diagnostic Testing for Influenza Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 21. Europe Rapid Diagnostic Testing for Influenza Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 22. Europe Rapid Diagnostic Testing for Influenza Market Share by Country (2019-2030)
    Figure 23. Germany Rapid Diagnostic Testing for Influenza Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. France Rapid Diagnostic Testing for Influenza Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. U.K. Rapid Diagnostic Testing for Influenza Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 26. Italy Rapid Diagnostic Testing for Influenza Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 27. Russia Rapid Diagnostic Testing for Influenza Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. Nordic Countries Rapid Diagnostic Testing for Influenza Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. Asia-Pacific Rapid Diagnostic Testing for Influenza Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. Asia-Pacific Rapid Diagnostic Testing for Influenza Market Share by Region (2019-2030)
    Figure 31. China Rapid Diagnostic Testing for Influenza Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Japan Rapid Diagnostic Testing for Influenza Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. South Korea Rapid Diagnostic Testing for Influenza Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Southeast Asia Rapid Diagnostic Testing for Influenza Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. India Rapid Diagnostic Testing for Influenza Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. Australia Rapid Diagnostic Testing for Influenza Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. Latin America Rapid Diagnostic Testing for Influenza Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 38. Latin America Rapid Diagnostic Testing for Influenza Market Share by Country (2019-2030)
    Figure 39. Mexico Rapid Diagnostic Testing for Influenza Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 40. Brazil Rapid Diagnostic Testing for Influenza Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 41. Middle East & Africa Rapid Diagnostic Testing for Influenza Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. Middle East & Africa Rapid Diagnostic Testing for Influenza Market Share by Country (2019-2030)
    Figure 43. Turkey Rapid Diagnostic Testing for Influenza Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. Saudi Arabia Rapid Diagnostic Testing for Influenza Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. BD Revenue Growth Rate in Rapid Diagnostic Testing for Influenza Business (2019-2024)
    Figure 46. Abbot (Alere) Revenue Growth Rate in Rapid Diagnostic Testing for Influenza Business (2019-2024)
    Figure 47. Quidel Revenue Growth Rate in Rapid Diagnostic Testing for Influenza Business (2019-2024)
    Figure 48. Roche Revenue Growth Rate in Rapid Diagnostic Testing for Influenza Business (2019-2024)
    Figure 49. Thermo Fisher Scientific Revenue Growth Rate in Rapid Diagnostic Testing for Influenza Business (2019-2024)
    Figure 50. Meridian Bioscience Revenue Growth Rate in Rapid Diagnostic Testing for Influenza Business (2019-2024)
    Figure 51. Analytik Jena Revenue Growth Rate in Rapid Diagnostic Testing for Influenza Business (2019-2024)
    Figure 52. Princeton BioMeditech Corporation Revenue Growth Rate in Rapid Diagnostic Testing for Influenza Business (2019-2024)
    Figure 53. BioMerieux Revenue Growth Rate in Rapid Diagnostic Testing for Influenza Business (2019-2024)
    Figure 54. Sekisui Diagnostics Revenue Growth Rate in Rapid Diagnostic Testing for Influenza Business (2019-2024)
    Figure 55. Response Biomedical Revenue Growth Rate in Rapid Diagnostic Testing for Influenza Business (2019-2024)
    Figure 56. SA Scientific Revenue Growth Rate in Rapid Diagnostic Testing for Influenza Business (2019-2024)
    Figure 57. DiaSorin (Focus Diagnostics) Revenue Growth Rate in Rapid Diagnostic Testing for Influenza Business (2019-2024)
    Figure 58. Wondfo Revenue Growth Rate in Rapid Diagnostic Testing for Influenza Business (2019-2024)
    Figure 59. Beijing Wantai Biological Pharmacy Revenue Growth Rate in Rapid Diagnostic Testing for Influenza Business (2019-2024)
    Figure 60. Bottom-up and Top-down Approaches for This Report
    Figure 61. Data Triangulation
    Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Traditional Chinese Medicine Fumigation Machines - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-2Q14216
Thu Nov 07 00:00:00 UTC 2024

Add to Cart

Immune-mediated Necrotizing Myopathy Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-6F13861
Wed Nov 06 00:00:00 UTC 2024

Add to Cart

Meningococcal Disease Vaccine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-37Q13661
Wed Nov 06 00:00:00 UTC 2024

Add to Cart

Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-9K14262
Wed Nov 06 00:00:00 UTC 2024

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions